🔴 Corcept Therapeutics is trading 4.25% down in pre-market

Corcept Therapeutics is trading at $111.50, down -4.25% before the October 21, 2026 session; no clear catalyst has been identified.

• The price compares with the October 20 close of $116.45.
• No clear company-specific announcement dated October 21 surfaced, and Corcept’s investor-relations releases page showed no newer release in the available results.
• Biotech ETF XBI was up 3.64% pre-market, which does not explain the decline.